IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q4 2020 Holdings

Filed 2021-02-16 | 17 holdings | $32.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$28.1M365,92687.0%
Argenx SE(ARGX)SPONSORED ADR04016X101$3.7M12,70011.6%
Spero Therapeutics Inc(SPRO)COM84833T103$76.2K3,932,2090.2%
Ishares TR(IBB)PutNASDAQ BIOTECH464287556$75.7K500,0000.2%
Spdr SER TR(XBI)PutS&P BIOTECH78464A870$70.4K500,0000.2%
Blueprint Medicines Corp(2L9)COM09627Y109$42.6K380,0120.1%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$30.5K1,005,5340.1%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$29.9K1,355,3920.1%
Anaptysbio Inc(ANAB)COM032724106$26.1K1,215,9580.1%
Uniqure NV(QURE)SHSN90064101$25.4K702,0500.1%
Regenxbio Inc(RGNX)COM75901B107$22.8K503,4440.1%
Magenta Therapeutics IncCOM55910K108$17.8K2,266,4230.1%
Amryt Pharma PLCSPONSORED ADS03217L106$11.3K800,0000.0%
Pieris Pharmaceuticals IncCOM720795103$9.2K3,675,5300.0%
Galapagos NV(GLPG)SPON ADR36315X101$6.9K69,9890.0%
Genmab A/S(GMAB)SPONSORED ADS372303206$3.7K90,0000.0%
4D Molecular Therapeutics in(FDMT)COM35104E100$82920,0000.0%